REG - Oxford Nanopore Tech - Issue of Equity and Total Voting Rights

Oxford Nanopore TechnologiesAnnouncement

Yesterday 16:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250501:nRSA1267Ha&default-theme=true

RNS Number : 1267H  Oxford Nanopore Technologies plc  01 May 2025

01 May 2025

Oxford Nanopore Technologies plc (the "Company")

Issue of Equity and Total Voting Rights

The Company today announces in respect of the month ended 30 April 2025, the
issue of 5,007,671 ordinary shares of £0.0001 each ("Ordinary Shares"),
following the exercise of options granted under the Company's share option
plans and issuance of shares under certain of the Company's remuneration
schemes.

Such Ordinary Shares were also admitted to the Official List of the Financial
Conduct Authority ("FCA") and to trading on the London Stock Exchange's main
market for listed securities under the Company's block listing facility.
Following this issue, the Company has the ability to admit a further
12,070,281 Ordinary Shares under its block listing facility.

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1,
the Company announces that as at 30 April 2025, the Company's issued share
capital consisted of 960,454,923 Ordinary Shares. The Company did not hold any
shares in treasury. Accordingly, the total number of voting rights in the
Company as at 30 April 2025 is 960,454,923. This figure may be used by
shareholders as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change to
their interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules. Enquiries:

Investors

ir@nanoporetech.com

Media

media@nanoporetech.com

OxfordNanoporeTechnologies@teneo.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVREASSFEELSEFA